IP Library Granted Patent US 8,361,005
Granted Patent B2
US 8,361,005 · App. 12/874,467 · Granted Jan 29, 2013

Blood separation and concentration system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,361,005
App. No.
12/874,467
Granted
Jan 29, 2013
Kind
B2
Abstract

This invention provides an apparatus and methods to consistently separate and concentrate selected blood components. The system includes, e.g., a computerized fluid handling system to transfer blood components between a centrifugal blood separation disc, containers and a concentrator.

Claims (33)

1. A method for producing concentrated blood components, the method comprising:

a) separating blood using centripetal force in a separation disk that rotates about a rotational axis;

b) detecting one or more red blood cell (RBC) interfaces with a first RBC detector at one or more levels of a separation disc, which RBC interface levels are predetermined to provide a desired composition of one or more separated components including buffy coat;

c) initiating collection of the buffy coat in response to the detecting;

d) collecting the separated components from an outlet port proximate to a rotational axis of the separation disc until RBCs are detected with a second RBC detector in the collection stream;

e) transferring the separated components through a conduit to a concentrator; and,

f) concentrating the separated components, which concentration comprises ultrafiltration;

thereby producing concentrated blood components.

2. The method of claim 1 , further comprising collecting a platelet poor blood plasma from the outlet port before the RBC interface is detected.

3. The method of claim 2 , wherein thrombin is produced from prothrombin present in the platelet poor blood plasma.

4. The method of claim 1 , further comprising isolating one or more growth factors, one or more compliment cascade proteins, or one or more coagulation factors from the concentrated blood components.

5. The method of claim 1 , further comprising contacting the concentrated blood components with thrombin to prepare a fibrin gel, a wound sealant or a bone graft substitute.

6. The method of claim 1 , wherein collecting the separated components comprises repeating cycles of collecting not more than about 10% of a separation disc volume and pausing collection for a time period.

7. The method of claim 1 , further comprising pausing separation or concentration processes and sampling of blood components before completion of processing.

8. The method of claim 1 , further comprising loading blood or blood components into the rotating separation disc.

9. The method of claim 8 , further comprising determining a total blood volume (V b ) loaded onto the separation disc, monitoring a separated component volume (V sc ), calculating an expected separated component volume (V sce ), and ending collection of separated components when the separated component volume (V sc ) equals the expected separated component volume (V sce ).

10. The method of claim 9 , further comprising calculating the expected separated component volume (V sce ) as the total blood volume (V b ) multiplied by a separation factor.

11. The method of claim 1 , further comprising determining a separated component volume (V sc ), calculating an expected concentrated component volume (W cce ), monitoring a concentrated component volume (V cc ), and ending concentration of separated components when the concentrated component volume (V cc ) equals the expected concentrated component volume (V cce ).

12. The method of claim 11 , further comprising calculating the expected concentrated component volume (V cce ) as the separated component volume (V sc ) multiplied by a concentration factor.

13. The method of claim 11 , wherein the concentrated component volume (V cc ) is calculated as the separated component volume (V sc ) minus a concentrator filtrate volume (V f ).

14. The method of claim 1 , wherein detecting in a), collecting in b), transferring in c) and concentrating in d) are performed by a single bench top instrument.

15. The method of claim 1 , further comprising monitoring detection in a), directing collection in b), directing transfer in c) and/or directing concentrating in d) with a control system.

16. A method for producing concentrated blood components, the method comprising:

providing a separation disk configured to receive whole blood through an inlet port and discharge lower density components of the whole blood through an outlet port;

rotating the separation disk about an axis causing the whole blood to be separated by centripetal force;

detecting, with a first red blood cell (RBC) detector, an interface level of the RBC;

initiating collection of the lower density components in response to the first RBC detector detecting an interface level that satisfies a predetermined level;

detecting, with a second RBC detector, a presence of RBC discharged through the outlet port; and

terminating the collecting of the lower density components in response to the second RBC detecting RBC discharged through the outlet port.

17. The method of claim 16 , further comprising transferring the lower density components from the outlet port to a concentrator.

18. The method of claim 17 , further comprising concentrating the lower density components by ultrafiltration.

19. The method of claim 16 , further comprising collecting a platelet poor blood plasma from the outlet port before the terminating of the collecting.

20. The method of claim 16 , further comprising determining a total blood volume (V b ) loaded onto the separation disc, monitoring a separated component volume (V sc ), calculating an expected separated component volume (V sce ), and ending collection of separated components when the separated component volume (V sc ) equals the expected separated component volume (V sce ).

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2018
From: BIOMET BIOLOGICS, LLC
To: BIOMET, INC.
Reel/Frame 045914/0262 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2018
From: ZB MANUFACTURING, LLC
To: BIOMET MANUFACTURING, LLC
Reel/Frame 045914/0335 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2018
From: BIOMET, INC.
To: ZB MANUFACTURING, LLC
Reel/Frame 045914/0350 →
CHANGE OF NAME Recorded Feb 24, 2014
From: BIOMET BIOLOGICS, INC.
To: BIOMET BIOLOGICS, LLC
Reel/Frame 032283/0573 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2014
From: INTERPORE ORTHOPAEDICS, INC.
To: BIOMET BIOLOGICS, INC.
Reel/Frame 032283/0590 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2014
From: ARM, DOUGLAS M.; PONTICIELLO, MICHAEL; MATHUR, SURINDER; HOOD, ANDREW G.
To: INTERPORE ORTHOPAEDICS, INC.
Reel/Frame 032283/0635 →